Japanese drugs firm Takeda has won shareholder approval for its £46bn (€51.5bn) acquisition of Shire. Japanese drugs firm Takeda has won shareholder approval for its £46bn (€51.5bn) acquisition of Shire. It hopes to complete the takeover on January 8, subject to approval from Shire shareholders who are due to meet later on Wednesday. Takeda reached a deal in May to buy Irish rival Shire for £49.01 a share to create a global pharmaceutical giant. Takeda expects the cash flow generated from the acquisition will help reduce the company's debt following completion.

Source: Irish Independent December 05, 2018 06:56 UTC